Ampio Pharmaceuticals has named Deborah Knobelman, Ph.D., chief business officer reporting directly to Ampio CEO, Don Wingerter.

Knobelman most recently served at Pfizer for three years as director of strategy and analytics for Pfizer's primary care product portfolio. Knobelman previously worked on Wall Street as an equity research analyst covering the specialty pharmaceuticals sector for several investment banks.